Sichuan Kelun Pharmaceutical Co Ltd (002422) — Cash Flow Reinvestment Rate
Sichuan Kelun Pharmaceutical Co Ltd (002422) has a Cash Flow Reinvestment Rate of 0.73x as of September 2025, reinvesting CN¥393.58 Million (capex CN¥393.58 Million ) from operating cash flow of CN¥537.31 Million. See Sichuan Kelun Pharmaceutical Co Ltd (002422) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sichuan Kelun Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Sichuan Kelun Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see how efficiently does Sichuan Kelun Pharmaceutical Co Ltd generate cash.
Annual Cash Flow Reinvestment Rate for Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)
Year-by-year capital reinvestment analysis for Sichuan Kelun Pharmaceutical Co Ltd. See 002422 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.73x | CN¥1.94 Billion | CN¥2.64 Billion | CN¥1.62 Billion | ▲ +84.5% |
| 2024 | 0.40x | CN¥1.78 Billion | CN¥4.49 Billion | CN¥1.68 Billion | ▼ -58.8% |
| 2023 | 0.96x | CN¥5.14 Billion | CN¥5.34 Billion | CN¥1.77 Billion | ▲ +71.8% |
| 2022 | 0.56x | CN¥1.75 Billion | CN¥3.13 Billion | CN¥896.02 Million | ▲ +1.7% |
| 2021 | 0.55x | CN¥1.57 Billion | CN¥2.85 Billion | CN¥990.56 Million | ▼ -24.1% |
| 2020 | 0.73x | CN¥1.61 Billion | CN¥2.22 Billion | CN¥1.23 Billion | ▼ -2.4% |
| 2019 | 0.74x | CN¥1.65 Billion | CN¥2.22 Billion | CN¥1.33 Billion | ▲ +34.5% |
| 2018 | 0.55x | CN¥1.63 Billion | CN¥2.95 Billion | CN¥1.33 Billion | ▼ -71.7% |
| 2017 | 1.95x | CN¥2.35 Billion | CN¥1.20 Billion | CN¥1.48 Billion | ▲ +86.4% |
| 2016 | 1.05x | CN¥1.81 Billion | CN¥1.73 Billion | CN¥1.37 Billion | ▼ -40.4% |
| 2015 | 1.76x | CN¥2.18 Billion | CN¥1.24 Billion | CN¥1.84 Billion | ▼ -22.3% |
| 2014 | 2.26x | CN¥2.76 Billion | CN¥1.22 Billion | CN¥2.76 Billion | ▲ +5.2% |
| 2013 | 2.15x | CN¥2.26 Billion | CN¥1.05 Billion | CN¥2.26 Billion | ▼ -68.8% |
| 2012 | 6.89x | CN¥2.77 Billion | CN¥402.77 Million | CN¥2.77 Billion | ▲ +17.8% |
| 2011 | 5.85x | CN¥2.00 Billion | CN¥342.93 Million | CN¥2.00 Billion | ▲ +34.8% |
| 2010 | 4.34x | CN¥647.22 Million | CN¥149.29 Million | CN¥647.22 Million | ▲ +294.8% |
| 2009 | 1.10x | CN¥275.29 Million | CN¥250.69 Million | CN¥275.29 Million | ▲ +7.1% |
| 2008 | 1.02x | CN¥226.58 Million | CN¥221.08 Million | CN¥226.58 Million | ▼ -1.4% |
| 2007 | 1.04x | CN¥175.05 Million | CN¥168.42 Million | CN¥175.05 Million | — |